ALBERT

Description: Current medical facilities usually lead to a very high cost especially for developing countries, rural areas and mass casualty incidents. Therefore, advanced electronic health systems are gaining momentum. In this paper, we first compared our novel off the shelf experimental wired Body Sensor Networks (BSN), that is, Digital First Aid (DigiAID) with the existing commercial product called as Hexoskin. We showed the viability of DigiAID through extensive real measurements during daily activities by both male and females. It was found that the major hurdle was wires to be worn by the subjects. Accordingly, we proposed and characterized the wireless DigiAID platform for wireless BSN (WBSN). Understanding the effect of body movements on wireless data transmission in WBSN is also of major importance. Therefore, this paper comprehensively evaluates and analyzes the impact of body movements, (a) to ensure transmission of data at different radio power levels and (b) its impact on the topology of the WBSN. Based on this we have proposed a dynamic power control algorithm that adapts the transmitting power according to the packet reception in an energy efficient manner. The results show that we have achieved substantial power savings at various nodes attached to the human body.

Description: Background Observational studies have consistently described poor clinical outcomes and increased ICU mortality in patients with severe coronavirus disease 2019 (COVID-19) who require mechanical ventilation (MV). Our study describes the clinical characteristics and outcomes of patients with severe COVID-19 admitted to ICU in the largest health care system in the state of Florida, United States. Methods Retrospective cohort study of patients admitted to ICU due to severe COVID-19 in AdventHealth health system in Orlando, Florida from March 11th until May 18th, 2020. Patients were characterized based on demographics, baseline comorbidities, severity of illness, medical management including experimental therapies, laboratory markers and ventilator parameters. Major clinical outcomes analyzed at the end of the study period were: hospital and ICU length of stay, MV-related mortality and overall hospital mortality of ICU patients. Results Out of total of 1283 patients with COVID-19, 131 (10.2%) met criteria for ICU admission (median age: 61 years [interquartile range (IQR), 49.5–71.5]; 35.1% female). Common comorbidities were hypertension (84; 64.1%), and diabetes (54; 41.2%). Of the 131 ICU patients, 109 (83.2%) required MV and 9 (6.9%) received ECMO. Lower positive end expiratory pressure (PEEP) were observed in survivors [9.2 (7.7–10.4)] vs non-survivors [10 (9.1–12.9] p = 0.004]. Compared to non-survivors, survivors had a longer MV length of stay (LOS) [14 (IQR 8–22) vs 8.5 (IQR 5–10.8) p〈 0.001], Hospital LOS [21 (IQR 13–31) vs 10 (7–1) p〈 0.001] and ICU LOS [14 (IQR 7–24) vs 9.5 (IQR 6–11), p 〈 0.001]. The overall hospital mortality and MV-related mortality were 19.8% and 23.8% respectively. After exclusion of hospitalized patients, the hospital and MV-related mortality rates were 21.6% and 26.5% respectively. Conclusions Our study demonstrates an important improvement in mortality of patients with severe COVID-19 who required ICU admission and MV in comparison to previous observational reports and emphasizes the importance of standard of care measures in the management of COVID-19.